Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.200 | X | 49253155 | missense variant | G/C | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.710 | 1.000 | 7 | 2000 | 2011 | ||||||||
|
1.000 | 0.200 | X | 49251698 | missense variant | A/C | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.800 | 1.000 | 6 | 2000 | 2011 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.040 | 1.000 | 4 | 2014 | 2019 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.040 | 1.000 | 4 | 2014 | 2019 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Immune System Diseases; Nervous System Diseases | 0.040 | 1.000 | 4 | 2015 | 2019 | ||||||||
|
1.000 | 0.200 | X | 49251480 | missense variant | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 3 | 2001 | 2017 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | 0.030 | 0.667 | 3 | 2011 | 2017 | ||||||||
|
0.851 | 0.320 | X | 49251440 | missense variant | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | ||||||||
|
0.827 | 0.280 | X | 49252667 | intron variant | T/C | snv | 0.30 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2018 | 2019 | |||||||
|
0.827 | 0.280 | X | 49252667 | intron variant | T/C | snv | 0.30 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2018 | 2019 | |||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2013 | 2013 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Pathological Conditions, Signs and Symptoms | 0.020 | 1.000 | 2 | 2014 | 2018 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases; Hemic and Lymphatic Diseases | 0.020 | 1.000 | 2 | 2013 | 2016 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2014 | 2018 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Immune System Diseases | 0.020 | 1.000 | 2 | 2013 | 2013 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2013 | 2013 | ||||||||
|
0.620 | 0.680 | X | 49261784 | intron variant | G/A;T | snv |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2013 | 2019 | ||||||||
|
0.724 | 0.480 | X | 49260888 | intron variant | G/A | snv | 9.6E-02 |
|
Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.724 | 0.480 | X | 49260888 | intron variant | G/A | snv | 9.6E-02 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||||
|
0.724 | 0.480 | X | 49260888 | intron variant | G/A | snv | 9.6E-02 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2018 | 2019 | |||||||
|
0.724 | 0.480 | X | 49260888 | intron variant | G/A | snv | 9.6E-02 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2018 | 2019 | |||||||
|
1.000 | 0.200 | X | 49258295 | splice donor variant | C/A;G | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 2 | 2001 | 2001 | ||||||||
|
0.716 | 0.480 | X | 49259429 | intron variant | T/C | snv |
|
Infections | 0.010 | 1.000 | 1 | 2019 | 2019 |